BI-7273 is primarily utilized in the field of cancer research, where it serves as a potent and selective inhibitor targeting specific proteins involved in tumor growth and survival. Its mechanism of action involves binding to and inhibiting the activity of these proteins, thereby disrupting signaling pathways that are crucial for cancer cell proliferation. This makes it a valuable tool in preclinical studies aimed at understanding the molecular basis of cancer and evaluating potential therapeutic strategies. Researchers employ BI-7273 in vitro and in vivo experiments to assess its efficacy in reducing tumor growth and metastasis. Additionally, it is used to explore combination therapies, where it may enhance the effectiveness of other anticancer agents. The insights gained from these studies contribute to the development of novel treatments for various types of cancer, offering hope for improved patient outcomes.